Concord Biotech Limited commences production of injectable at new facility

Concord Biotech Limited has successfully commissioned and commenced production of injectable at our new manufacturing facility situated at Valthera.

This advanced facility has been meticulously designed and constructed to adhere to stringent international standards, equipped with cutting-edge technology to ensure the consistent delivery of high-quality products.

The operationalization of Unit-4 represents a significant milestone in the Company's strategic growth initiatives.

Shares of Concord Biotech Limited was last trading in BSE at Rs. 1659.00 as compared to the previous close of Rs. 1676.20. The total number of shares traded during the day was 2591 in over 534 trades.

The stock hit an intraday high of Rs. 1716.50 and intraday low of 1646.65. The net turnover during the day was Rs. 4332440.00.

Source : Equity Bulls

Keywords

ConcordBiotech Pharmaceuticals INE338H01029 CommercialProduction Injectable Valthera ManufacturingFacility